{"id":34095,"date":"2014-10-15T11:23:04","date_gmt":"2014-10-15T15:23:04","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=34095"},"modified":"2014-10-15T11:23:04","modified_gmt":"2014-10-15T15:23:04","slug":"novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095","title":{"rendered":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/15\/2014 (wallstreetpr) \u2013\u00a0<strong>Novavax, Inc. (NASDAQ:NVAX)<\/strong> has initiated second phase clinical trial of its study concerning the evaluation of respiratory syncytial virus (RSV) vaccine on pregnant women.<\/p>\n<p style=\"text-align: justify;\"><strong>Aim Of The Study<\/strong><\/p>\n<p style=\"text-align: justify;\">As briefed in the <a href=\"http:\/\/globenewswire.com\/news-release\/2014\/09\/16\/666476\/10098907\/en\/Novavax-Initiates-Phase-2-Clinical-Trial-of-RSV-F-Protein-Nanoparticle-Vaccine-Candidate-in-Healthy-Third-Trimester-Pregnant-Women.html\" target=\"_blank\">article<\/a>, the biopharmaceutical company has started enrollment in the second phase of the RSV F-protein nanoparticle vaccine. Healthy women in the third trimester of their pregnancy have been chosen as subjects for the study.<\/p>\n<p style=\"text-align: justify;\">The study aims at evaluating the immunogenicity and safety of the vaccine in the subjects. It seeks to assess the effect of maternal immunization on the safety of the infant for a period of 12 months. In addition, the trial will also determine the levels of RSV-specific antibodies generated over a six-month period.<\/p>\n<p style=\"text-align: justify;\">In relation to this, the President and Chief Executive Officer of Novavax, Inc. (NASDAQ:NVAX), Stan Erck, believes the start of the trial to be a watershed event for the company. The company seeks to improve infant health, and this achievement marks an important milestone in this direction, commented the Senior Vice President of the company\u2019s research and development unit, Greg Glenn.<\/p>\n<p style=\"text-align: justify;\"><strong>RSV And RSV Vaccine<\/strong><\/p>\n<p style=\"text-align: justify;\">RSV is one the most important factors in infant morbidity and mortality across the world. It is a key respiratory pathogen and poses a great threat to the infant, as well as the elderly population. Novavax attempts to develop a vaccine to be administered to women when they are still pregnant to benefit the infant. The company sees this as the best means to protect newly born children as they are prone to fatal diseases linked with RSV.<\/p>\n<p style=\"text-align: justify;\">Novavax, Inc. (NASDAQ:NVAX) has adopted an organized and disciplined approach in the development of the vaccine. The enrollment in the trial underlines its step-by-step plan and stands out as a significant inflection point. The company had also followed the approach in the development of other immunogenicity and clinical safety evaluating trials. One such drug was the palivizumab (Synagis\u2122).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/15\/2014 (wallstreetpr) \u2013\u00a0Novavax, Inc. (NASDAQ:NVAX) has initiated second phase clinical trial of its study concerning the evaluation of respiratory syncytial virus (RSV) vaccine [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":34096,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[10973,6461,6460,10972],"stock_ticker":[],"class_list":["post-34095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-greg-glenn","tag-nasdaqnvax","tag-novavax-inc-nasdaqnvax","tag-stan-erck","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/15\/2014 (wallstreetpr) \u2013\u00a0Novavax, Inc. (NASDAQ:NVAX) has initiated second phase clinical trial of its study concerning the evaluation of respiratory syncytial virus (RSV) vaccine [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-15T15:23:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine\",\"datePublished\":\"2014-10-15T15:23:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\"},\"wordCount\":340,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg\",\"keywords\":[\"Greg Glenn\",\"NASDAQ:NVAX\",\"Novavax Inc. (NASDAQ:NVAX)\",\"Stan Erck\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\",\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg\",\"datePublished\":\"2014-10-15T15:23:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095","og_locale":"en_US","og_type":"article","og_title":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR","og_description":"Boston, MA 10\/15\/2014 (wallstreetpr) \u2013\u00a0Novavax, Inc. (NASDAQ:NVAX) has initiated second phase clinical trial of its study concerning the evaluation of respiratory syncytial virus (RSV) vaccine [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-15T15:23:04+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine","datePublished":"2014-10-15T15:23:04+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095"},"wordCount":340,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg","keywords":["Greg Glenn","NASDAQ:NVAX","Novavax Inc. (NASDAQ:NVAX)","Stan Erck"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095","url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095","name":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg","datePublished":"2014-10-15T15:23:04+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/Novavax-Inc.jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-enrolls-pregnant-women-in-second-phase-study-of-rsv-vaccine-34095#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=34095"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34095\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/34096"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=34095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=34095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=34095"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=34095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}